India’s Dengue Vaccine Trial Reaches 70%
India’s first dengue vaccine, DengiAll, reaches 70% enrolment in Phase III trials. It could protect against all four dengue virus strains. In many Indian cities, the hum of fogging machines…
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes. The Hyderabad-based vaccine…
